Assembly Biosciences Inc — キャッシュフロー (NASDAQ:ASMB) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -62.96 M-93.4 M-84.46 M22.74 M-51.12 M-41.09 M -41.09 M 投資活動によるキャッシュフロー 68.07 M26.52 M90.64 M-69.14 M40.17 M-113.47 M -113.47 M 財務活動によるキャッシュフロー 7.6 M53.06 M614 K13.82 M29.45 M174.67 M 174.67 M フリーキャッシュフロー -63.43 M-96.49 M-84.56 M22.49 M-51.15 M-41.16 M -41.16 M

ニュース

Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB)

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates

Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Assembly Biosciences (NASDAQ:ASMB), Gilead Sciences (NASDAQ:GILD)

Gilead exercises option for Assembly Bio’s herpes treatment programs

ジェフリーズ、アセンブリー・バイオサイエンシズの目標株価をHSVデータを受け62ドルに引き上げ

Jefferies raises Assembly Biosciences stock price target to $62 on HSV data

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies Transcript

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies - Slideshow (NASDAQ:ASMB) 2025-12-08